1-2 of 2
Jessica Casaletto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1455: RLY-4008, a novel precision therapy for FGFR2-driven cancers designed to potently and selectively inhibit FGFR2 and FGFR2 resistance mutations

Free
Jessica Casaletto, Dejan Maglic, B. Barry Toure, Alex Taylor, Heike Schoenherr, Brandi Hudson, Kamil Bruderek, Songping Zhao, Patrick O'Hearn, Nastaran Gerami-Moayed, Demetri Moustakas, Roberto Valverde, Lindsey Foster, Hakan Gunaydin, Pelin Ayaz, Dina Sharon, Donald Bergstrom, James Watters
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1455.
https://doi.org/10.1158/1538-7445.AM2021-1455
Published: 01 July 2021
View articletitled, Abstract 1455: RLY-4008, a novel precision therapy for FGFR2-driven cancers designed to potently and selectively inhibit FGFR2 and FGFR2 resistance mutations
Journal Articles

retSDR1, a Short-Chain Retinol Dehydrogenase/Reductase, Is Retinoic Acid-inducible and Frequently Deleted in Human Neuroblastoma Cell Lines

Available to Purchase
Fabio Cerignoli, Xiaojia Guo, Beatrice Cardinali, Christian Rinaldi, Jessica Casaletto, Luigi Frati, Isabella Screpanti, Lorraine J. Gudas, Alberto Gulino, Carol J. Thiele, Giuseppe Giannini
Journal: Cancer Research
Cancer Res (2002) 62 (4): 1196–1204.
Published: 01 February 2002
View articletitled, retSDR1, a Short-Chain Retinol Dehydrogenase/Reductase, Is Retinoic Acid-inducible and Frequently Deleted in Human Neuroblastoma Cell Lines
Open the PDF for retSDR1, a Short-Chain Retinol Dehydrogenase/Reductase, Is Retinoic Acid-inducible and Frequently Deleted in Human Neuroblastoma Cell Lines in another window